Patients who monitor themselves at home for proper dosing of the blood thinner warfarin seem to do just as well as patients who are monitored in a doctor's office, according to a study published in the New England Journal of Medicine.

A program designed to help people with type 2 diabetes lose and keep off extra weight led to improved diabetes control and cardiovascular disease risk factors. The finding suggests that lifestyle changes can have long-term benefits for overweight and obese people with diabetes.

Small changes in weight can make bigger differences in the blood pressure for overweight children, compared to those at normal weight, according to a new study.

Treating metabolic syndrome and undergoing carotid angioplasty may prevent recurrent stroke or transient ischaemic attack (TIA), according to revised American Heart Association/American Stroke Association guidelines.

The treatment of a range of human blood cancers such as chronic myelomonocytic leukaemia and juvenile myelomonocytic leukaemia may be improved as a result of international research involving the University of Western Australia.

Measuring three biomarkers in a single blood sample may improve physicians' ability to identify patients at high risk of developing chronic kidney disease (CKD), according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

Surgical patients with known heart disease risks who are given beta blockers around the time of surgery have a significantly reduced risk of post-operative death compared with patients not given beta blockers, according to a study by researchers at the San Francisco VA Medical Center.

Treating hospital patients with thigh-length surgical stockings, rather than knee-high socks, can reduce the chance of developing life threatening blood clots by 30 per cent, according to groundbreaking new research from the University of Sydney.

Researchers have found that magnetic resonance imaging (MRI) may be sufficient for the routine surveillance of some great vessel (primary blood vessels [e.g. aorta and vena cavae]) stents that are commonly used to treat congenital heart defects (a defect in the structure of the heart and great vessels that is present at birth) in children and young adults, according to a study in the October ...

An oral medication produces significant and lasting relief for patients with myelofibrosis, a debilitating and lethal bone marrow disorder, researchers at the University of Texas MD Anderson Cancer Center report in the 16 September New England Journal of Medicine.